Richard I. Fisher, Fox Chase Cancer Center
This is Richard I. Fisher, M.D., who was named president and CEO of Fox Chase Cancer Center.

Contact: Diana Quattrone
diana.quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center

Maintenance Therapy for Metastatic Colorectal Cancer: Practice before Evidence?
F. Ciardiello shares his comments on perspectives and potentials to change the current practice in the management of metastatic colorectal cancer, based on results from two studies on maintenance ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

Nationwide NSCLC Study Provides Data on the Value of Molecular Screening for Targeted Treatment
R. Dziadziuszko underlines the importance of widening the range of screened biomarkers, the potential benefits in terms of treatment appropriateness for patients and the added value of broad ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

Radioactive Iodine-Refractory Thyroid Cancer: Sorafenib, a New Treatment Option
L. Licitra shares her comments about randomized, phase III DECISION trial that studied sorafenib, an orally active inhibitor of VEGFR1-3 and Raf kinases, vs. placebo in patients with progressive ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

Amplification of c-MET: A Study of Resistance to Anti-EGFR Therapies in Colorectal Cancer
F. Ciardiello shares his comments on a next generation sequencing study applied to identify genetic alterations in patients with metastatic colorectal cancer who do not develop K-ras mutations during ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

Novelties to Target Immune Pathways in Cancer
Giuseppe Curigliano offers an overview on current cancer research focused on T-regulators and T-effectors and opens hopes for future progress studying ways to re-activate the immune system and ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

The Role of Tumor's Microenvironment in Cancer Growth and Progression
This shows humor-host interaction: how they speak and what they say. Giuseppe Curigliano explains the "dialogue" between the tumor and the microenvironment surrounding it, highlighting the important ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

IMPAKT 2013 -- Translational Research in Breast Cancer: Program Highlights
Heterogeneity of breast cancer; multigene signatures to determine prognosis; biopsying metastases; emerging pathways; new imaging techniques... This and much more awaits you at IMPAKT if you want a ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

IMPAKT Breast Cancer Conference: How to Move Forward Toward Personalized Medicine
Metastatic breast cancer: what hopes for what is called an orphan disease? Andrew Tutt and Peter Dubsky, IMPAKT 2013 co-chairs, highlight new approaches to deal with this condition and the discussions...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

How Breast Cancer Cells Get Into The Brain
A representative image of breast cancer brain metastasis induced by human CTCs following injection into mice. This work provides first-time evidence of CTC isolation and establishment and ...

Contact: Science Press Package
scipak@aaas.org
202-326-6440
American Association for the Advancement of Science